We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ferndale Adverse Event Procedure Cited in FDA’s Form 483
Ferndale Adverse Event Procedure Cited in FDA’s Form 483
December 7, 2009
Ferndale Laboratories’ complaint records are deficient because they don’t include investigation and follow-up findings, a Form 483 says, and
the company doesn’t fully review all lack-of-efficacy complaints.